Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

AT&T Is Ailing, and Investors Should Unload T Stock

By Larry Ramer, InvestorPlace Contributor
Going forward, AT&T is facing many risks, including accelerated cord cutting and reduced post-pandemic spending on hardware. T stock is a sell.

Don’t Buy Sundial Stock: As the Saying Goes, Hundreds of Flowers Are Blooming

By GS Early
SNDL stock is one of many cannabis stocks that's trying to gain a foothold in a dynamic market in Canada, with the US still in the wings.

Uncertainties, Unknowns Make Skillz Stock Too Risky

By Larry Ramer, InvestorPlace Contributor
Due to esports' relatively low popularity and the high valuation of SKLZ stock, the shares are unattractive at these levels.

Nio Stock Still Has a Great Story and Valuation Issues

By Vince Martin, InvestorPlace Contributor
The EV selloff has hit NIO stock. But its $60 billion market capitalization still prices in a huge amount of growth for any auto manufacturer.

Virgin Galactic Shows What Can Go Wrong with a SPAC

By Dana Blankenhorn, InvestorPlace Contributor
By the end of the decade you may be able to fly halfway around the world in 30 minutes. But likely not on Virgin Galactic or SPCE stock.

Do Not Ignore The Red Flags Associated With Fisker 

By Vandita Jadeja
With no revenue and a car that exists only on paper, Fisker is all about speculation. There is too much risk associated with FSR stock.

Coinbase: Three Weeks After Its IPO, Is It a $400 or $200 Stock?

By Will Ashworth, InvestorPlace Contributor
Coinbase jumped 31% on its first day of trading. It’s been downhill since. Is Coinbase a $400 or $200 stock? Here’s a look at both arguments.

Sell General Electric Stock Into This Strength

By InvestorPlace Research Staff
An industrial recovery has boosted GE stock. But long-running problems remain, and the risks of a failed turnaround are simply too high.

Crypto Itself Remains a Better Choice Than Marathon Digital Stock

By Thomas Niel, InvestorPlace Contributor
What remains your better option? The cryptos themselves. Even as Bitcoin has bounced back towards its prior highs, while MARA stock has not, it makes sense why it's played out this way. Don't use it as justification to buy this stock on its recent pullback.

C3.ai Stock Still Looks High Despite Its Impressive and Unique Growth

By Mark R. Hake, CFA
C3.ai stock still looks high despite its growth. AI stock at 32 times revenue is too high despite its 32% growth rate.

The Bears Know Best: Stay Away From HYLN Stock

By Alex Sirois, InvestorPlace Contributor
HYLN stock is a SPAC funded EV has been which never should have received so much attention. Nothing's improved since then.

Beware: The Selloff in Jumia Technologies Stock Can Continue

By InvestorPlace Research Staff
Investors piled into JMIA stock amid a small-cap rally. After a reversal, disappointing growth and a steep valuation should deter investors.

Lordstown Motors Stock Is a Bottom of the Barrel EV Play

By InvestorPlace Research Staff
As the prior hype behind Lordstown Motors fades due to many red flags, it's clear RIDE stock isn't a great way to play the EV megatrend.

The Bull and Bear Cases for FuelCell Stock: Will It Resume Its Rise or Continue to Fall?

By Chris MacDonald, InvestorPlace Contributor
Investors looking for a green-energy growth play have looked at FCEL stock as a high-leverage way to play the green-energy revolution.

Spurred On by Analysts, Snowflake Remains Highly Overvalued

By Mark R. Hake, CFA
Snowflake stays in its own weird, overvalued world. At best, SNOW stock is worth 30 times revenue, or 16% lower than today.

Canoo Is Absolutely a Sell, Based on Persistent Troubles

By Alex Sirois, InvestorPlace Contributor
GOEV stock shouldn't be rewarded with investment capital now or anytime soon. The company is in trouble based on recent news.

Why Ocugen Stock Continues to Be a Great Short Opportunity

By Larry Ramer, InvestorPlace Contributor
No U.S. government official has made positive comments about approving Covaxin and the Covaxin trials do not seem to meet the FDA's preferences. OCGN stock is a short.

Don’t Chase Ocugen Stock Without Reading the Fine Print

By InvestorPlace Research Staff
OCGN stock has soared on positive vaccine data. But investors must remember that Ocugen's market and experience are sharply limited.

Quantumscape Stock Has No Business Trading, and You Have No Business Buying It

By Dana Blankenhorn, InvestorPlace Contributor
Quantumscape is a development stage company working on a solid state lithium-ion battery that would be superior to current models, assuming things work out.
Load More Articles